DAVID L GRANGE Insider Trading $PPDI PHARMACEUTICAL PRODUCT DEVELOPMENT INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID L GRANGE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID L GRANGE. DAVID L GRANGE is Director in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI) and Director in Tonix Pharmaceuticals Holding Corp. ($TNXP).
DAVID L GRANGE in PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Trading Symbol: PPDIIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of DAVID L GRANGE: Director
Holdings: 11,045 shares
Latest Transaction: Jan 05 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DAVID L GRANGE in PHARMACEUTICAL PRODUCT DEVELOPMENT INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 05 2009 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Grant | A | 0.00 | 2,242 | 0 | 11,045 | 8.8 K to 11 K (+25.47 %) |
Aug 08 2008 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Option Exercise | M | 35.38 | 3,973 | 140,565 | 0 | |
Aug 08 2008 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Option Exercise | M | 33.82 | 6,126 | 207,181 | 0 | |
Aug 08 2008 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Sell | S | 41.35 | 10,099 | 417,594 | 8,803 | 18.9 K to 8.8 K (-53.43 %) |
Aug 08 2008 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Buy | M | 35.38 | 3,973 | 140,565 | 18,902 | 14.9 K to 18.9 K (+26.61 %) |
Aug 08 2008 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Buy | M | 33.82 | 6,126 | 207,181 | 14,929 | 8.8 K to 14.9 K (+69.59 %) |
May 22 2008 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Option Exercise | A | 42.77 | 6,265 | 267,954 | 6,265 | |
Jan 04 2008 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Grant | A | 0.00 | 1,588 | 0 | 8,803 | 7.2 K to 8.8 K (+22.01 %) |
Jul 27 2007 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Option Exercise | M | 23.79 | 5,458 | 129,846 | 0 | |
Jul 27 2007 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Sell | S | 33.77 | 4,300 | 145,211 | 7,215 | 11.5 K to 7.2 K (-37.34 %) |
Jul 27 2007 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Sell | S | 33.76 | 658 | 22,214 | 11,515 | 12.2 K to 11.5 K (-5.41 %) |
Jul 27 2007 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Sell | S | 33.75 | 500 | 16,875 | 12,173 | 12.7 K to 12.2 K (-3.95 %) |
Jul 27 2007 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Buy | M | 23.79 | 5,458 | 129,846 | 12,673 | 7.2 K to 12.7 K (+75.65 %) |
May 18 2007 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Option Exercise | A | 33.82 | 6,126 | 207,181 | 6,126 | |
Feb 12 2007 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Option Exercise | M | 15.06 | 6,000 | 90,360 | 6,000 | |
Feb 12 2007 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Sell | S | 33.97 | 779 | 26,463 | 7,215 | 8 K to 7.2 K (-9.74 %) |
Feb 12 2007 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Sell | S | 34.00 | 1,558 | 52,972 | 7,994 | 9.6 K to 8 K (-16.31 %) |
Feb 12 2007 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Sell | S | 34.11 | 1,169 | 39,875 | 9,552 | 10.7 K to 9.6 K (-10.90 %) |
Feb 12 2007 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Sell | S | 34.16 | 779 | 26,611 | 10,721 | 11.5 K to 10.7 K (-6.77 %) |
Feb 12 2007 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Sell | S | 34.25 | 390 | 13,358 | 11,500 | 11.9 K to 11.5 K (-3.28 %) |
Feb 12 2007 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Sell | S | 34.38 | 1,325 | 45,554 | 11,890 | 13.2 K to 11.9 K (-10.03 %) |
Feb 12 2007 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Buy | M | 15.06 | 6,000 | 90,360 | 13,215 | 7.2 K to 13.2 K (+83.16 %) |
Jan 04 2007 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Grant | A | 0.00 | 1,991 | 0 | 7,215 | 5.2 K to 7.2 K (+38.11 %) |
May 24 2006 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Option Exercise | M | 15.06 | 10,000 | 150,600 | 6,000 | |
May 24 2006 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Sell | S | 36.24 | 10,000 | 362,400 | 5,224 | 15.2 K to 5.2 K (-65.69 %) |
May 24 2006 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Buy | M | 15.06 | 10,000 | 150,600 | 15,224 | 5.2 K to 15.2 K (+191.42 %) |
May 18 2006 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Option Exercise | A | 35.38 | 3,973 | 140,565 | 3,973 | |
Jan 04 2006 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Grant | A | 0.00 | 1,032 | 0 | 2,612 | 1.6 K to 2.6 K (+65.32 %) |
Nov 03 2005 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Option Exercise | M | 25.76 | 5,000 | 128,800 | 10,729 | |
Nov 03 2005 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Sell | S | 57.00 | 1,000 | 57,000 | 1,580 | 2.6 K to 1.6 K (-38.76 %) |
Nov 03 2005 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Sell | S | 56.91 | 1,000 | 56,910 | 2,580 | 3.6 K to 2.6 K (-27.93 %) |
Nov 03 2005 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Sell | S | 56.85 | 1,000 | 56,850 | 3,580 | 4.6 K to 3.6 K (-21.83 %) |
Nov 03 2005 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Sell | S | 56.75 | 1,000 | 56,750 | 4,580 | 5.6 K to 4.6 K (-17.92 %) |
Nov 03 2005 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Sell | S | 56.92 | 1,000 | 56,920 | 5,580 | 6.6 K to 5.6 K (-15.20 %) |
Nov 03 2005 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Buy | M | 25.76 | 5,000 | 128,800 | 6,580 | 1.6 K to 6.6 K (+316.46 %) |
Jul 27 2005 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Option Exercise | M | 25.76 | 3,000 | 77,280 | 15,729 | |
Jul 27 2005 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Sell | S | 57.45 | 1,800 | 103,410 | 1,580 | 3.4 K to 1.6 K (-53.25 %) |
Jul 27 2005 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Sell | S | 57.44 | 1,200 | 68,928 | 3,380 | 4.6 K to 3.4 K (-26.20 %) |
Jul 27 2005 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Buy | M | 25.76 | 3,000 | 77,280 | 4,580 | 1.6 K to 4.6 K (+189.87 %) |
May 26 2005 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Option Exercise | A | 47.58 | 2,729 | 129,846 | 18,729 | |
Jan 04 2005 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Grant | A | 0.00 | 1,580 | 0 | 1,580 | 0 to 1.6 K |
May 20 2004 | PPDI | PHARMACEUTICAL PRO ... | GRANGE DAVID L | Director | Option Exercise | A | 30.11 | 8,000 | 240,880 | 16,000 |
Page: 1